MetLife Investment Management’s Ardent Health ARDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$120K Hold
14,030
﹤0.01% 2453
2025
Q4
$124K Sell
14,030
-592
-4% -$6.84K ﹤0.01% 2501
2025
Q3
$194K Hold
14,622
﹤0.01% 2335
2025
Q2
$200K Hold
14,622
﹤0.01% 2197
2025
Q1
$201K Buy
14,622
+7,253
+98% +$106K ﹤0.01% 2199
2024
Q4
$126K Hold
7,369
﹤0.01% 2520
2024
Q3
$135K Buy
+7,369
New +$130K ﹤0.01% 2489

Other funds holding ARDT

MetLife Investment Management's ARDT Position: Q1 2026 in Review

MetLife Investment Management held its Ardent Health (ARDT) position steady in Q1 2026 at 14,030 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #2453.

MetLife Investment Management first reported a position in ARDT in Q3 2024 and has held it in 7 quarters since. The position peaked at $201K in Q1 2025. 136 funds tracked by Wall St. Rank hold ARDT as of Q1 2026.

  • MetLife Investment Management held 14,030 shares of Ardent Health worth $120K as of Q1 2026.
  • MetLife Investment Management left its Ardent Health share count unchanged in Q1 2026.
  • Ardent Health made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2453 holding.
  • MetLife Investment Management first reported a position in Ardent Health in Q3 2024 and has held it in 7 quarters since.
  • MetLife Investment Management's Ardent Health position peaked at $201K in Q1 2025.
  • 136 funds tracked by Wall St. Rank held Ardent Health as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.